Aclaris Therapeutics
ACRS
ACRS
127 hedge funds and large institutions have $957M invested in Aclaris Therapeutics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 26 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1% more call options, than puts
Call options by funds: $362K | Put options by funds: $357K
0.32% more ownership
Funds ownership: 95.03% → 95.35% (+0.32%)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
Holders
127
Holding in Top 10
9
Calls
$362K
Puts
$357K
Top Buyers
| 1 | +$4.25M | |
| 2 | +$3.91M | |
| 3 | +$2.6M | |
| 4 |
BlackRock
New York
|
+$2.21M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.88M |
Top Sellers
| 1 | -$22.8M | |
| 2 | -$2.27M | |
| 3 | -$2.13M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.54M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.53M |